Prolyl oligopeptidase inhibition by N-acyl-pro-pyrrolidine-type molecules. 2008

Károly Kánai, and Péter Arányi, and Zsolt Böcskei, and György Ferenczy, and Veronika Harmat, and Kálmán Simon, and Sándor Bátori, and Gábor Náray-Szabo, and István Hermecz
CHINOIN, Ltd, H-1045 Budapest, Hungary.

Three novel, N-acyl-pro-pyrrolidine-type, inhibitors of prolyl oligopeptidase (POP) with nanomolar activities were synthesized and their binding analyzed to the host enzyme in the light of X-ray diffraction and molecular modeling studies. We were interested in the alteration in the binding affinity at the S3 site as a function of the properties of the N-terminal group of the inhibitors. Our studies revealed that, for inhibitors with flat aromatic terminal groups, the optimal length of the linker chain is three C-C bonds, but this increases to four C-C bonds if there is a bulky group in the terminal position. Molecular dynamics calculations indicate that this is due to the better fit into the binding pocket. A 4-fold enhancement of the inhibitor activity upon replacement of the 4-CH2 group of the proline ring by CF2 is a consequence of a weak hydrogen bond formed between the fluorine atom and the hydroxy group of Tyr473 of the host enzyme. There is notably good agreement between the calculated and experimental free energies of binding; the average error in the IC50 values is around 1 order of magnitude.

UI MeSH Term Description Entries
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011759 Pyrrolidines Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH. Tetrahydropyridine,Tetrahydropyridines
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006860 Hydrogen Bonding A low-energy attractive force between hydrogen and another element. It plays a major role in determining the properties of water, proteins, and other compounds. Hydrogen Bonds,Bond, Hydrogen,Hydrogen Bond
D000085822 Prolyl Oligopeptidases A family of serine proteases with specificity for proline-specific cleavage of peptides that are not longer than 30 amino acids. In humans it is broadly distributed in all tissues with higher activity found in the brain. Post-Proline Cleaving Enzyme,Post-Proline Endopeptidase,Proline Endopeptidase,Proline Specific Endopeptidase,Prolyl Endopeptidase,Prolyl Endopeptidase (Thiol-dependent),Prolyl Endopeptidase I,Prolyl Oligopeptidase,Endopeptidase I, Prolyl,Endopeptidase, Post-Proline,Endopeptidase, Proline Specific,Oligopeptidases, Prolyl,Post Proline Cleaving Enzyme,Post Proline Endopeptidase
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D012697 Serine Endopeptidases Any member of the group of ENDOPEPTIDASES containing at the active site a serine residue involved in catalysis. Serine Endopeptidase,Endopeptidase, Serine,Endopeptidases, Serine
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer

Related Publications

Károly Kánai, and Péter Arányi, and Zsolt Böcskei, and György Ferenczy, and Veronika Harmat, and Kálmán Simon, and Sándor Bátori, and Gábor Náray-Szabo, and István Hermecz
August 2003, Bioorganic & medicinal chemistry,
Károly Kánai, and Péter Arányi, and Zsolt Böcskei, and György Ferenczy, and Veronika Harmat, and Kálmán Simon, and Sándor Bátori, and Gábor Náray-Szabo, and István Hermecz
September 2002, Journal of medicinal chemistry,
Károly Kánai, and Péter Arányi, and Zsolt Böcskei, and György Ferenczy, and Veronika Harmat, and Kálmán Simon, and Sándor Bátori, and Gábor Náray-Szabo, and István Hermecz
October 2003, Journal of medicinal chemistry,
Károly Kánai, and Péter Arányi, and Zsolt Böcskei, and György Ferenczy, and Veronika Harmat, and Kálmán Simon, and Sándor Bátori, and Gábor Náray-Szabo, and István Hermecz
May 1996, Journal of neurochemistry,
Károly Kánai, and Péter Arányi, and Zsolt Böcskei, and György Ferenczy, and Veronika Harmat, and Kálmán Simon, and Sándor Bátori, and Gábor Náray-Szabo, and István Hermecz
January 2020, Pharmacological research,
Károly Kánai, and Péter Arányi, and Zsolt Böcskei, and György Ferenczy, and Veronika Harmat, and Kálmán Simon, and Sándor Bátori, and Gábor Náray-Szabo, and István Hermecz
July 2010, Bioorganic & medicinal chemistry,
Károly Kánai, and Péter Arányi, and Zsolt Böcskei, and György Ferenczy, and Veronika Harmat, and Kálmán Simon, and Sándor Bátori, and Gábor Náray-Szabo, and István Hermecz
February 2002, Cellular and molecular life sciences : CMLS,
Károly Kánai, and Péter Arányi, and Zsolt Böcskei, and György Ferenczy, and Veronika Harmat, and Kálmán Simon, and Sándor Bátori, and Gábor Náray-Szabo, and István Hermecz
November 2005, Journal of medicinal chemistry,
Károly Kánai, and Péter Arányi, and Zsolt Böcskei, and György Ferenczy, and Veronika Harmat, and Kálmán Simon, and Sándor Bátori, and Gábor Náray-Szabo, and István Hermecz
June 2021, Natural product research,
Károly Kánai, and Péter Arányi, and Zsolt Böcskei, and György Ferenczy, and Veronika Harmat, and Kálmán Simon, and Sándor Bátori, and Gábor Náray-Szabo, and István Hermecz
January 1984, Journal of neurochemistry,
Copied contents to your clipboard!